All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: HBV-HIV Coinfection-27381922

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	27381922	P127L	S	S	HBV-HIV Coinfection	G R I C L	View
2	27381922	P127T	S	S	HBV-HIV Coinfection	G R I C L	View
3	27381922	S136Y	S	S	HBV-HIV Coinfection	G R I C L	View
4	27381922	A21T	P	P	HBV-HIV Coinfection	G R C L	View
5	27381922	C121Y	S	S	HBV-HIV Coinfection	G R I C L	View
6	27381922	C124F	S	S	HBV-HIV Coinfection	G R I C L	View
7	27381922	L115V	P	P	HBV-HIV Coinfection	G R C L	View
8	27381922	T123I	S	S	HBV-HIV Coinfection	G R I C L	View
9	27381922	H124N	RT	P	HBV-HIV Coinfection	G R C L	View
10	27381922	S135Y	RT	P	HBV-HIV Coinfection	G R C L	View
11	27381922	C345A	S	S	HBV-HIV Coinfection	G R I C L	View
12	27381922	C379A	S	S	HBV-HIV Coinfection	G R I C L	View
13	27381922	C380T	S	S	HBV-HIV Coinfection	G R I C L	View
14	27381922	C407A	S	S	HBV-HIV Coinfection	G R I C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.